Abstract-The diagnosis of low insulin sensitivity is commonly done through the HOMA-IR index, in which fasting insulin and glucose blood levels are evaluated. Insulin and blood glucose levels are used for insulin sensitivity assessment by surrogate methods (HOMA-IR, Matsuda, etc), but anthropometric measurements like body weight, height and waist circumference are not considered, even if these variables also are related to low insulin sensitivity and metabolic syndrome. In this study we evaluate the impact of anthropometric measurements on the HOMA-IR, Matsuda and Caumo indexes to estimate insulin sensitivity. Specifically, we compare insulin sensitivity indexes with and without the anthropometric measurements in their equations on three different groups: patients with metabolic syndrome, sedentaries and marathoners. Results show relationships between anthropometric variables and insulin sensitivity indexes. On the other hand, subjects are mapped differently for insulin sensitivity assessment when anthropometric variables are taken into account. In addition, subjects diagnosed with normal insulin sensitivity could be considered as having low insulin sensitivity when anthropometric variables are considered.
I. INTRODUCTION
Hyperinsulinemic euglycemic clamp [1] is the gold standard method for low insulin sensitivity estimation (a.k.a. insulin resistance). However, this accurate technique is highly invasive, risky and expensive; it is thus mainly used for research purposes. Alternative less invasive methods have been conceived to determine insulin sensitivity. These indirect or surrogate methods are generally less accurate than the direct ones, but are easier to use since few variables are taken into account in the computation process.
HOMA-IR, Matsuda and Caumo methods are examples of surrogate methods for insulin sensitivity estimation [2] , [3] , [4] . These methods use different variables to assess insulin sensitivity. For instance, HOMA-IR only uses fasting insulin and glucose blood levels, Matsuda's method uses insulin and glucose levels from the 5-sample oral glucose tolerance test (OGTT * ), and Caumo's method, a more complicated equation, not only requires insulin and glucose levels from the 5-sample OGTT but also the area under the curves of insulin and glucose.
The HOMA-IR is the only surrogate method used for low insulin sensitivity diagnosis, even when it has poor accuracy in different populations [5] . Indeed, HOMA-IR's accuracy is limited to patients that already suffer from low insulin sensitivity and it decreases when insulin secretion by beta cells becomes insufficient, e.g. in patients with type 2 diabetes [6] . However, the accuracy of surrogate methods can be improved by means of optimization methods [7] . HOMA-IR is unable to detect low insulin sensitivity in its early stages because fasting insulin and blood glucose alterations only take place when the disease is in advanced stages, i.e. the metabolic dysfunctions are already present. In this sense, HOMA-IR's performance can be seen as the evaluation of beta cells' work to maintain blood glucose in normal levels. Using other surrogate methods when metabolic alterations are present could lead to misdiagnoses. Finding the ideal method to assess insulin sensitivity and diagnose low insulin sensitivity on specific populations remains thus a challenge.
Metabolic syndrome condition and low insulin sensitivity ailment can be developed or aggravated in the presence of other factors [5] , [8] , [9] . In this sense, we are interested in other physiological variables, in addition to insulin and glucose blood levels, that could be used for low insulin sensitivity diagnosis. For instance, a wide waist circumference, a variable related to the intra-abdominal fat, has been associated with low insulin sensitivity [10] and is crucial in the diagnosis of metabolic syndrome. The body mass index (BMI), the ratio between body weight and height, is also associated with low insulin sensitivity and is an important fator for the prediction of metabolic syndrome [8] .
The first objective of this work is to compare HOMA-IR, Matsuda and Caumo indexes on three groups: patients with metabolic syndrome, sedentaries and marathoners. Then, we include anthropometric measurements to the original equations that define these indexes and evaluate the insulin sensitivity on the same data. Finally, we compare insulin sensitivity indexes when anthropometric measurements are considered and when these variables are not considered.
II. METHODS

A. Glucose, insulin and anthropometric data
Insulin and glucose blood levels were obtained from 40 subjects through a 5-sample OGTT. Body weight (W , referring to a person's mass), height (h) and waist circumference (wc) were also measured. These subjects were divided into three groups: 15 subjects diagnosed with metabolic syndrome (DB1) according to [11] , 10 sedentary people without metabolic syndrome (DB2) and 15 marathoners (DB3) with a 180-240 km distance of weekly training. The study protocol adhered to the principles of the Declaration of Helsinki and was approved by the Ethical Committee of the University Hospital of Caracas; all the subjects gave a written informed consent.
B. Insulin sensitivity assessment
Insulin sensitivity (IS) was calculated using HOMA-IR (1), Matsuda (2) and Caumo's (3) methods (see next page for equation 3). In equations (1) and (2), I 0 (µUI/mL) and G 0 (mg/dL) are the fasting insulin and glucose blood levels (minute 0), and I m and G m are the mean insulin and glucose blood levels measured in the 5-sample OGTT:
is the fraction of the ingested glucose dose that appears in the systemic circulation, D oral is the ingested glucose dose per unit of body weight (mg/kg), AUC denotes the area under the curve, GE is the glucose effectiveness (ml per kg/min), G(t) is the plasma glucose concentration, ∆G(t) = G(t) − G b is the glucose excursion above basal (G b ), I(t) is the plasma insulin concentration, ∆I(t) = I(t) − I b is the insulin excursion above basal (I b ), 0 is the time corresponding to the beginning of the OGTT, t 0 is the time instant where ∆G(t) becomes negative, and T is the time corresponding to the end of the OGTT (T = 120 minutes in our experiments).
C. Anthropometric measurements and IS relationships
The BMI was retained as a quantitative variable that relates the body weight and the height: BMI = W/h 2 . For each indirect method two scatter plots were made, one to explore the relationships between the BMI and the IS index and other to explore the relationships between the wc and the IS index.
D. Including anthropometric measurements on IS equations
Since we hypothesized that the wc and the BMI could provide additional information for insulin sensitivity assessment, we modified equations (1), (2) and (3) to include these variables. From previous scatter plots (see the result section for details) we observed that the BMI and the wc were directly related to the HOMA-IR index but were non-linear inversely related to the Matsuda and Caumo indexes. Therefore, we included the wc and the BMI as shown in equations (4), (5) and (6) . We call these the extended indexes. 
E. Low IS diagnosis
Because HOMA-IR is the only index used to classify subjects as TRUE/FALSE low insulin sensitivity (above 2.5 implies low insulin sensitivity), we classified subjects from DB1, DB2 and DB3 according to it. We also observed how the classified subjects were mapped by the other methods (the original and the extended indexes).
F. Statistical analysis
Summary statistics were computed for all variables analyzed in this work: glucose, insulin, IS index, etc. The Mann-Whitney U test was used to evaluate the differences between the median values of the three data sample groups (DB1 vs DB2, DB1 vs DB3, DB2 vs DB3), where p-values less than 0.05 were considered statistically significant. According to the HOMA-IR index, 9 subjects from DB1 (60%) were classified as low IS. Subjects from DB2 and DB3
III. RESULTS
were all classified as normal IS. Table I shows the median, the first quartile and the third quartile of the variables analyzed in this work for each data sample. We found that DB1 has higher median (p < 0.05) than DB2 and DB3 in glucose (G 0 , G 1 , . . . , G 4 ) and insulin (I 0 , I 1 , . . . , I 4 ), and DB2 has higher median than DB3 (p < 0.05) in the same variables. Additionally, the median of W and wc is statistically higher (p < 0.05) in DB1 compared to DB2 and DB3, and the median of these variables is higher (p < 0.05) in DB2 compared to DB3. The results of IS indexes are shown in Fig. 2 as box plots. The medians of the IS indexes IS H and IS H are statistically higher in DB1 compared to DB2 and DB3, and DB1 has a higher IS index median than DB2. In contrast, the medians of the IS indexes IS M and IS M are statistically higher in DB3 compared to DB2 and DB1, and in DB2 compared to DB1. The median of IS C and IS C are statistically higher in DB3 compared to DB1, and in DB2 compared to DB1, however we fail to reject the null hypothesis that the medians of IS C and of IS C in DB2 and DB3 are equal, respectively. Fig. 3 shows IS H vs IS H , IS M vs IS M and IS C vs IS C after normalization. We can see in this figure that subjects from DB1, DB2 and DB3 are mapped differently when anthropometric measurements are taken into account for insulin sensitivity assessment (y-axis). We can see in Fig. 3a that a fixed value cannot be used in IS H to separate low IS and normal IS, we also observe that two subjects from DB1 that were diagnosed as normal IS could be diagnosed as low IS using the extended HOMA-IR index. In Fig. 3b we see that a fixed value can perfectly separate low IS subjects from normal IS using IS M and IS M . In the case of Caumo (Fig.  3c) , we observed that a fixed value cannot separate low IS subjects from normal IS neither using the original index nor the extended one. Even two subjects diagnosed as normal IS (one from DB2 and another from DB3) are neighbors from the low IS subjects cluster (bottom left corner).
IV. DISCUSSION
The scatter plots that relate quantitative variables BMI and wc to IS indexes (see Fig. 1 ) show that a relationship exists between them. This suggests that these variables could provide additional information in the assessment of insulin sensitivity and in telling apart different populations. We observed that IS is lower in subjects with impaired of glucose, insulin, wc and BMI than in subjects that only present impaired glucose and insulin values.
The fact that DB3 has lower median of glucose and insulin in all phases of the OGTT suggests that marathoners have a more damped metabolic response compared with sedentary and metabolic syndrome subjects. The pancreas of marathoners seems to reduce glucose levels with less insulin production, i.e. the metabolization process is more efficient in marathoners. Specialists should take into account these aspects to avoid misdiagnosis when reading the results of these IS indexes.
We observed that subjects are mapped differently for the IS indexes studied. For example, consider the rightmost red square (subject from DB1 with low IS) in Fig. 3a . This subject has almost half of the IS value when mapped from IS H to IS H . Also, in the same figure, two subjects from DB1, which were not considered as low insulin sensitivity by HOMA-IR, could be considered as low insulin sensitivity when anthropometric variables are taken into account. Similarly, a subject from DB2 which is in the borderline for low insulin sensitivity by HOMA-IR is now distant in the extended index for low insulin sensitivity. This fact reveals that when anthropometric variables are included in the HOMA-IR equation, this method could be used to diagnose low insulin sensitivity on subjects without impaired fasting glucose and insulin.
V. CONCLUSIONS AND FUTURE WORKS
In this paper we have shown that anthropometric variables like waist circumference, and body weight and height (included in the body mass index function) could provide additional information to improve the insulin sensitivity assessment and diagnose low insulin sensitivity (insulin resistance syndrome). We have also shown that subjects diagnosed as suffering from low insulin sensitivity by the HOMA-IR index are mapped differently by the other surrogate methods, and when anthropometric variables are integrated into the HOMA-IR equation, subjects diagnosed as normal insulin sensitivity could be diagnosed as low insulin sensitivity.
In future works we are interested in applying unsupervised machine learning techniques like K-means clustering or anomaly detection algorithms to identify patients with low insulin sensitivity among the data sample.
